This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Find the latest science, technology and partners in antibody engineering, immunobiology and next generation binders.

Novel and Difficult Targets in Antibody Drug Discovery

Share this article

Rated the most important area of antibody therapeutic development by industry professionals earlier this year, novel targets for therapeutic antibodies incur their own challenges in the discovery process.

In this ebook, we explore leading strategies in handling novel and difficult targets in therapeutic antibody discovery, including transforming targets or using innovative platforms to overcome the obstacles.

We invite you to join us as we look at insights from Genovac, Genscript, Retrogenix and more.

Explore or download the interactive eBook by clicking on the image above or here.

Share this article

Upcoming event

Antibody Engineering & Therapeutics US

12 - 16 Dec 2021, Marriott Marquis San Diego
THE #1 ANTIBODY ENGINEERING CONFERENCE FOR ACCELERATING NEXT GENERATION ANTIBODIES TO COMMERCIAL SUCCESS
Go to site